Other
NT-501 CNTF implant
NT-501 CNTF implant is an intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
COMBINATION PRODUCT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_1
2
50%
Ph phase_2
1
25%
Ph phase_3
1
25%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
Trials by Status
active_not_recruiting125%
completed375%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_3
A Study to Determine the Safety and Efficacy of NT-501 With MHFM
NCT06397131
completedphase_2
Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2
NCT04729972
completedphase_1
NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
NCT01411657
completedphase_1
NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement
NCT01408472
Clinical Trials (4)
Showing 4 of 4 trials
NCT06397131Phase 3
A Study to Determine the Safety and Efficacy of NT-501 With MHFM
NCT04729972Phase 2
Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2
NCT01411657Phase 1
NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
NCT01408472Phase 1
NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement
All 4 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 4